New Concepts in Management of Otospongiosis
| Autor: | J. Causse, Valvassori Ge, L. G. Chevance, Petrovic A, George E. Shambaugh |
|---|---|
| Rok vydání: | 1974 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Vein graft Stapes Surgery Transplantation Autologous Cochlear function Veins Fluorides chemistry.chemical_compound Sodium fluoride medicine Humans Polytetrafluoroethylene Postoperative Care Aspirin business.industry Prostheses and Implants General Medicine Stapedectomy Stainless Steel Cochlea Surgery Otosclerosis Otorhinolaryngology chemistry business Medical therapy medicine.drug |
| Zdroj: | Archives of Otolaryngology - Head and Neck Surgery. 100:419-426 |
| ISSN: | 0886-4470 |
| DOI: | 10.1001/archotol.1974.00780040433003 |
| Popis: | Polytef (Teflon) piston against vein graft stapedectomy is currently preferred with frequent assessment of cochlear function during the first three critical weeks so that medical therapy can be directed toward any cochlear drop. Moderate dosage of sodium fluoride is recommended preoperatively for six months to one year, for active otospongiosis. Postoperatively it is prescribed for two years or longer for active cochlear otospongiosis with skeletal surveys once every two years to monitor the skeletal effects. Preliminary data indicate a favorable effect of moderate dosage sodium fluoride in a high percentage of patients in arresting progressive sensorineural loss due to otospongiosis. This treatment is as safe and perhaps safer than a moderate dosage of aspirin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|